Shiva Rama Krishna Muppalla

Abstract Sunitinib (SUNI) is a small-molecule tyrosine kinase inhibitor with limited water solubility, extensive first-pass metabolism, and low oral bioavailability, restricting its therapeutic efficacy. This study aimed to enhance SUNI …